Who We Are

Meet the team

Evologic’s operative team combines comprehensive pharmaceutical industry know-how and experience with the enthusiasm and drive of young team members. Employing’s 25 members from 10 countries, each member brings a unique perspective and personality to the team. We speak German, English, Turkish, Russian, Filipino, Ukranian, Farsi, Spanish, Hungarian, Italian and French.

The background of the team members includes bio-processing, chemical engineering, agronomy, electronics, mechatronics, molecular biology, and food processing science. This combination of different cultures and theoretical backgrounds is the foundation for our creativity and our motivation to arrive at the most suitable solution to the challenges we encounter.

Our roots in academia

Evologic is a SpinOff of the Technical University of Vienna, institute of Chemical Engineering. Having developed technologies to maximize productivity for manufacturing of pharmaceuticals, the founding team switched gears and transferred to the agricultural market. The academic incubators and accelerators of INITS and the I2C greatly facilitated the first steps from science to business.

Supporters

Investors

Milestones

May 2022

Calyxt Announces Agreement with Evologic Technologies to Scale Production of its Plant-based Ingredients

Evologic will work alongside Calyxt to grow and scale Calyxt’s proprietary PCM™ technology. Specifically, Evologic will advance the manufacturing of PCM™-derived compounds and subsequently scale multiple PCMs simultaneously for commercial production.

17 May 2020

AAFC partners up with Evologic on commercialisation of biological glyphosate replacement

Agriculture and Agri-Food Canada (AAFC) has developed the Phoma macrostoma technology as a biological alternative to conventional herbicide use. In 2020, AAFC invited potential industry partners by a Request for Proposals to commercialize this technology. Evologic Technologies submitted a proposal based on their proposed proprietary and highly innovative production technology, which features a promising opportunity for large scale market introduction of the biological herbicide. Evologic Technologies is pleased to announce that its proposal was successful. To date, Evologic and AAFC are discussing the details of transfer of the Phoma macrostoma technology.

1 Jan 2020